Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-3029

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 71335-3029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353029)

Each tablet contains Olmesartan Medoxomil and Hydrochlorothiazide in the dosage of 20 mg and 12.5 mg respectively. The tablets come with a package insert that provides prescribing information for dosage and administration. Storage instructions recommend keeping the tablets at 20° to 25° C (68° to 77° F) with excursions permitted to 15° to 30° C (59° to 86° F). They need to be dispensed in a tight, light-resistant container. The product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Macleods Pharmaceuticals Ltd. Keep the tablets out of reach of children.*

FDA Label Image

505 (Olmesartan Hctz Structure)

FDA Label Image

505 (Olmesartan Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.